Letter to the editor:  What about incorporating selenium in the therapeutic regimen of SARS-COV-2?

Pandiella Alonso, Atanasio; Benarba, Bachir

doi:10.17179/excli2020-2968

Título

Letter to the editor: What about incorporating selenium in the therapeutic regimen of SARS-COV-2?

dc.contributor.author	Pandiella Alonso, Atanasio
dc.contributor.author	Benarba, Bachir
dc.date.accessioned	2021-03-04T10:43:24Z
dc.date.available	2021-03-04T10:43:24Z
dc.date.issued	2020
dc.identifier.citation	Benarba, B. ; Atanasio Pandiella, A. (2020). Letter to the editor: What about incorporating selenium in the therapeutic regimen of SARS-COV-2?. EXCLI Journal, 19,pp. 1544-1546. doi: 10.17179/excli2020-2968	es_ES
dc.identifier.uri	http://hdl.handle.net/10366/145495
dc.description.abstract	[ES] Carta al editor en la que se expresan las ventajas de utilizar selenio en los tratamientos terapéuticos del SARS-CoV-2.	es_ES
dc.language.iso	eng	es_ES
dc.publisher	EXCLI Journal	es_ES
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject	COVID-19	es_ES
dc.subject	SARS-CoV-2	es_ES
dc.subject	Selenium	es_ES
dc.subject.mesh	Coronavirus	*
dc.title	Letter to the editor: What about incorporating selenium in the therapeutic regimen of SARS-COV-2?	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.relation.publishversion	https://doi.org/10.17179/excli2020-2968
dc.subject.unesco	3205.05 Enfermedades Infecciosas	es_ES
dc.subject.unesco	3205.08 Enfermedades Pulmonares	es_ES
dc.identifier.doi	10.17179/excli2020-2968
dc.rights.accessRights	info:eu-repo/semantics/openAccess	es_ES
dc.journal.title	EXCLI Journal	es_ES
dc.volume.number	19	es_ES
dc.page.initial	1544	es_ES
dc.page.final	1546	es_ES
dc.type.hasVersion	info:eu-repo/semantics/publishedVersion	es_ES
dc.subject.decs	coronavirus	*